https://orcid.org/0000-0002-1719-9891
References
- Dalmau J, Armangue T, Planaguma J, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045–1057. doi:10.1016/S1474-4422(19)30244-3
- Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J. Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis. JAMA Neurol. 2013;70:1133–1139. doi:10.1001/jamaneurol.2013.3216
- Wong D, Fries B. Anti-NMDAR encephalitis, a mimicker of acute infectious encephalitis and a review of the literature. IDCases. 2014;1(4):66–67. doi:10.1016/j.idcr.2014.08.003
- Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study. Lancet Neurol. 2013;12(2):157–165. doi:10.1016/S1474-4422(12)70310-1
- Balu R, McCracken L, Lancaster E, Graus F, Dalmau J, Titulaer MJ. A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology. 2019;92(3):e244–e252. doi:10.1212/WNL.0000000000006783
- Gbadero DA, Adegbite EO, LePichon JB, Slusher TM. Case presentation of anti-NMDA receptor encephalitis in a 4-year-old boy. J Trop Pediatr. 2018;64(4):352–354. doi:10.1093/tropej/fmx070
- Roos IB. Autoimmune encephalitis: a missed diagnostic and therapeutic opportunity. African J Neurological Sci. 2017;36(2):66–79.
- Wang HY, Li T, Li XL, Zhang XX, Yan ZR, Xu Y. Anti-N-methyl-D-aspartate receptor encephalitis mimics neuroleptic malignant syndrome: case report and literature review. Neuropsychiatr Dis Treat. 2019;15:773–778. doi:10.2147/NDT.S195706
- Sokhi DS, Bhogal OS. Autoimmune encephalitis is recognised as an important differential diagnosis in a Kenyan Tertiary Referral Centre. BMJ Mil Health. 2020;166(5):358. doi:10.1136/jramc-2019-001338
- Bacchi S, Franke K, Wewegama D, Needham E, Patel S, Menon D. Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: a systematic review. J Clin Neurosci. 2018;52:54–59. doi:10.1016/j.jocn.2018.03.026
- Guasp M, Dalmau J. Encephalitis associated with antibodies against the NMDA receptor. Med Clin (Barc). 2018;151(2):71–79. doi:10.1016/j.medcli.2017.10.015
- Schumacher LT, Mann AP, MacKenzie JG. Agitation management in pediatric males with anti-N-Methyl-D-Aspartate receptor encephalitis. J Child Adolesc Psychopharmacol. 2016;26(10):939–943. doi:10.1089/cap.2016.0102
- Mohammad SS, Jones H, Hong M, et al. Symptomatic treatment of children with anti-NMDAR encephalitis. Dev Med Child Neurol. 2016;58(4):376–384. doi:10.1111/dmcn.12882
- Lalani HS, Waweru-Siika W, Mwogi T, et al. Intensive care outcomes and mortality prediction at a National Referral Hospital in Western Kenya. Ann Am Thorac Soc. 2018;15(11):1336–1343. doi:10.1513/AnnalsATS.201801-051OC
- Nelson SE, Nyquist PA. Autoimmune encephalitis in the intensive care unit. Neurointensive Care Unit. 2020;249–263.